These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6206202)

  • 1. Localization of a neutralization epitope of foot-and-mouth disease virus using neutralizing monoclonal antibodies.
    Duchesne M; Cartwright T; Crespo A; Boucher F; Fallourd A
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1559-66. PubMed ID: 6206202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An epitope located at the C terminus of isolated VP1 of foot-and-mouth disease virus type O induces neutralizing activity but poor protection.
    Meloen RH; Barteling SJ
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():289-94. PubMed ID: 2418152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12.
    Robertson BH; Morgan DO; Moore DM
    Virus Res; 1984 Sep; 1(6):489-500. PubMed ID: 6085200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.
    Bolwell C; Clarke BE; Parry NR; Ouldridge EJ; Brown F; Rowlands DJ
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():59-68. PubMed ID: 2471783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment.
    Baxt B; Morgan DO; Robertson BH; Timpone CA
    J Virol; 1984 Aug; 51(2):298-305. PubMed ID: 6205165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenicity and immunogenicity of synthetic peptides of foot-and-mouth disease virus.
    Meloen RH; Puyk WC; Meijer DJ; Lankhof H; Posthumus WP; Schaaper WM
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():305-14. PubMed ID: 2434606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-sensitive site of foot-and-mouth disease virus.
    Ouldridge EJ; Barnett PV; Parry NR; Syred A; Head M; Rweyemamu MM
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():203-7. PubMed ID: 6198448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of antigenic variants of foot-and-mouth disease virus by polyacrylamide gel electrophoresis of their structural polypeptides.
    Knowles NJ; Hedger RS
    Vet Microbiol; 1985 Jun; 10(4):347-57. PubMed ID: 2412337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a group protein in foot-and-mouth disease virus particles.
    Talbot P; Rowlands DJ; Burroughs JN; Sangar DV; Brown F
    J Gen Virol; 1973 Jun; 19(3):369-80. PubMed ID: 4353213
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of an exposed region of the immunogenic capsid polypeptide VP1 on foot-and-mouth disease virus.
    Robertson BH; Moore DM; Grubman MJ; Kleid DG
    J Virol; 1983 Apr; 46(1):311-6. PubMed ID: 6186823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.
    Rowlands DJ; Sangar DV; Brown F
    J Gen Virol; 1975 Mar; 26(3):227-38. PubMed ID: 235596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites.
    Xie QC; McCahon D; Crowther JR; Belsham GJ; McCullough KC
    J Gen Virol; 1987 Jun; 68 ( Pt 6)():1637-47. PubMed ID: 2438378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies.
    Grubman MJ; Morgan DO
    Virus Res; 1986 Oct; 6(1):33-43. PubMed ID: 3026110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A].
    Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN
    Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
    Meloen RH; Briaire J
    J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.